Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 2

Status

Completed 120Recruiting 29Unknown 24Terminated 20Active not recruiting 15Withdrawn 4Suspended 2Not yet recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 79Breast 11Thoracic 7Gynecologic 4Genitourinary 4Sarcoma 2CNS 2Other 1Lymphoid 1Head & Neck 1

Conditions

Prostatic Neoplasms 240Carcinoma, Renal Cell 74Urinary Bladder Neoplasms 56Kidney Neoplasms 31Breast Neoplasms 26Neoplasms 25Carcinoma, Transitional Cell 22Neoplasm Metastasis 21Carcinoma, Non-Small-Cell Lung 14Sarcoma 11Non-Muscle Invasive Bladder Neoplasms 11Lung Neoplasms 11Melanoma 10Wilms Tumor 8Testicular Neoplasms 8Colorectal Neoplasms 8Uterine Cervical Neoplasms 7Urologic Neoplasms 7Stomach Neoplasms 7Pancreatic Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Small Cell Lung Carcinoma 6Recurrence 6Ovarian Neoplasms 6Endometrial Neoplasms 6Carcinoma, Hepatocellular 6Carcinoma 6Prostatic Neoplasms, Castration-Resistant 5Neuroblastoma 5Esophageal Neoplasms 5

Interventions

bexmarilimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × Colonic Neoplasms × Genitourinary × Clear all
NCT05471401 2024-06-13

GI Organ Tracking Via Balloon Applicators

Washington University School of Medicine

Phase NA Withdrawn
GastrointestinalGenitourinaryHead & NeckThoracic

Colonic Neoplasms, Esophageal Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT05104905 2022-05-11

RENACOL

Faron Pharmaceuticals Ltd

Phase 1/2 Withdrawn
GastrointestinalGenitourinary

Carcinoma, Renal Cell, Colonic Neoplasms

NCT03408561 2019-09-17

Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer

University of Southern California

Phase NA Withdrawn
BreastGastrointestinalGenitourinaryLymphoidThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Lymphoma, Prostatic Neoplasms

NCT01176500 2017-07-02

A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1/2 Withdrawn
GastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Colonic Neoplasms, Lung Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡